Dexamethasone intraocular injection - Icon Bioscience

Drug Profile

Dexamethasone intraocular injection - Icon Bioscience

Alternative Names: DEXYCU; IBI-10090

Latest Information Update: 13 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Icon Bioscience
  • Class Anti-inflammatories; Antiemetics; Antineoplastics; Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Ocular inflammation

Most Recent Events

  • 12 Feb 2018 Registered for Ocular inflammation in USA (Intraocular)
  • 26 Jun 2017 FDA assigns PDUFA action date of 12/02/2018 for dexamethasone intraocular injection for Ocular inflammation
  • 26 Jun 2017 US FDA accepts NDA for dexamethasone intraocular injection for Ocular inflammation for review
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top